FINANCIAL CONFLICT OF INTEREST POLICY
|
|
- Damon Crawford
- 5 years ago
- Views:
Transcription
1 FINANCIAL CONFLICT OF INTEREST POLICY Individuals who are appointed to serve on ABIM boards or committees are expected to have the American Board of Internal Medicine s (ABIM) mission as their primary interest when contributing to ABIM s work. A real or perceived conflict of interest may arise when, due to another interest that may compete with those of ABIM, an individual has the opportunity to influence ABIM work in ways that could lead to, or appear to lead to, personal or institutional gain, or advantage for another organization. This Conflict of Interest Policy is intended to provide guidelines for identifying and managing conflicts that arise from competing interests. It is intended to maintain the integrity of ABIM s decision-making processes and, thereby, maintain the confidence of the profession and the public in ABIM s standards and judgments. This policy applies to members of the Board of Directors, the ABIM Council, Specialty Boards, Exam Committees, Medical Knowledge Self-Assessment Product Committees, and any other standing and ad hoc committees or task forces of ABIM that develop ABIM policies or products. Those in service to ABIM on these or subsequently created entities are referred to collectively as members. The policy applies to public and interprofessional members as well as to physician members. Because the work of members in different groups varies considerably in focus, different types of management may be indicated for specific groups. Rationale The benefits of collaboration between physicians and healthcare-related industries (including but not limited to pharmaceutical companies, medical device makers, health information technology companies, health insurance companies and for-profit medical education companies, referred to collectively as industry ) are evident in the advances in therapies and technologies that have resulted from such relationships. ABIM recognizes that members who are well-suited to promote ABIM s mission through service on its boards and committees may have relationships with industry in a variety of ways, including funding of research, funding of educational activities, licensing of intellectual property and personal investments in healthcarerelated for-profit companies. In addition to the potential benefits to patients, these relationships may be valued by physicians for reasons distinct from financial compensation received, including interaction with colleagues, exposure to new ideas and the opportunity to share their own work. ABIM also recognizes that relationships with industry can introduce the risk of industry influence that may not be recognized by the individuals involved in the relationships, especially when the financial value of a relationship is high. Concern within the medical profession and the public about the influence of industry on many aspects of medicine has grown in recent decades; thus, ABIM further recognizes that the appearance of industry influence on its products and policies is a risk to ABIM, even if no actual influence on decision-making occurs. There are several tools available to help ABIM assure that competing interests do not affect decision-making by members on behalf of ABIM. These include detailed disclosure about the nature of the relationships (including products involved and members roles); open discussion among members of a group concerning those relationships and their possible impact on the work of the group; proactive management plans; and, in some cases, prohibition of certain types 1
2 of activities. In addition, the perspective of members who have no financial relationships with industry can help in assuring that decisions made on behalf of ABIM are free of industry influence; all boards and committees should therefore include members who have no financial relationships with industry, as described in Appendix A. Guidelines ABIM s financial conflict of interest policy outlines the areas in which industry frequently collaborates with physicians and other health care professionals, and defines activities that are allowed during board service and those that are prohibited. ABIM recognizes that exceptions may be appropriate in some circumstances. It is anticipated that this policy will evolve over time, as society, the profession and ABIM evolve. Appendix A describes the procedures that ABIM employs to administer this policy. These procedures are also expected to evolve over time as ABIM learns from the initial implementation of the policy what works and what could be improved. Although the policy applies to all members, management plans may differ for different groups. For example, if a member of an Exam Committee or Medical Knowledge Self-Assessment Product Committee acts as a consultant to industry concerning a particular drug or receives research funding for a clinical trial that includes that drug, questions written by the member that relate to this drug will be flagged so that the entire Committee can carefully consider whether or not there is any industry influence in the question. The work of the Specialty Boards, Council and Board of Directors is very different, but this policy applies to all members. A staff-level conflict of interest committee, working with the Chief Ethics Officer and overseen by the Conflict of Interest Subcommittee, will determine when additional management is necessary, and will provide management plans. Types of Activities and Compatibility with ABIM Service In determining which activities are to be allowed and which are to be prohibited during ABIM service, the potential value of different types of activities, principally to the public but also to the involved members, was considered, along with potential risk to ABIM. This risk includes not only the introduction of industry influence into decisions affecting ABIM s programs, policies and products, but also the risk of public perception of industry influence on its work. Activities that were judged as having high risk are judged to be incompatible with ABIM service. Research Activities Many members, both within and outside of academic settings, engage in research activities that are linked with industry. ABIM recognizes that such work may be of considerable benefit to society, and that it may also be vital to the careers of some researchers. The following activities are compatible with ABIM service, with detailed disclosure of the relationship: Funding for preclinical research. Funding for clinical trials, including salary support and other expenses. 2
3 Travel expenses associated with attending investigators meetings. Travel expenses and honoraria for service on data and safety monitory boards. The following activities are compatible with ABIM service, but may require management beyond disclosure, as described in Appendix A: Honoraria for attendance at investigators meetings. Travel expenses and honoraria for service on a research-related expert panel/advisory board. Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities. Post-marketing clinical research. In addition, because the likelihood of influence increases when the financial value of a relationship is high, members with above-salary income from consulting fees, honoraria or similar income above a specified level from any single company during a twelve-month period will be asked to provide additional information about their relationship with that company to determine if any additional management is needed. This level is specified in Appendix A and is expected to change over time. Educational Activities Many members are involved in educational activities, including basic science courses for medical students and others, clinical precepting of trainees in a variety of settings, and continuing medical education for practicing physicians. ABIM values the educational contributions of its members but recognizes that some types of activities may raise considerable public concern about industry influence in the profession. Standards of the Accreditation Council for Continuing Medical Education (ACCME) and of some individual institutions attempt to mitigate bias related to industry influence. The following activities are compatible with ABIM service, with detailed disclosure of the relationship: Work funded by educational grants, when grants are made to an institution or organization (rather than directly to the member). Continuing medical education funded by industry, when funding is provided to an institution or organization (rather than directly to the member). The following activities are compatible with ABIM service, but may require management beyond disclosure, as described in Appendix A: Work funded by educational grants, when grants are made to the member (rather than to an institution or organization). Continuing medical education funded by industry, when funding is provided to the member (rather than to an institution or organization) and the member controls all content of the educational activity. Teaching in industry-funded satellite symposia (e.g., sessions that are held in conjunction with specialty society meetings), provided that the member controls the content of his/her presentation. 3
4 Industry-funded training that is required by the FDA, in which the member as trainee receives no payment from industry and in which the member as trainer may receive from industry a reasonable fee or honorarium (e.g., FDA-required training on a new device). In addition, because the likelihood of influence increases when the financial value of a relationship is high, members with above-salary income from consulting fees, honoraria or similar income above a specified level from any single company during a twelve-month period will be asked to provide additional information about their relationship with that company to determine if any additional management is needed. This level is specified in Appendix A and is expected to change over time. The following activities are considered to be incompatible with ABIM service, because there is potential for strong industry influence in these activities, and because they are viewed as having less value to society and/or to the career of a member than other types of industryfunded educational activities: Any educational activity in which the speaker does not control the content (e.g., teaching using slides prepared by a pharmaceutical company). Industry-funded peer discussion groups (e.g., case discussion over dinner when industry provides an honorarium to the member to attend the dinner). Industry-funded, hands-on mentoring that is not required by the FDA (e.g., training other health care professionals in the use of a specific device, when the device maker provides an honorarium to the member for providing or receiving the training). Teaching or attending industry-sponsored events for trainees where industry controls the content. Intellectual Property Physicians and other health care professionals may work with industry in the development of intellectual property, including but not limited to therapeutic agents, diagnostic tests or approaches, information technology, and educational materials. ABIM recognizes the potential value of such work to the public and to the careers of its members. The following intellectual property relationships with industry are compatible with ABIM service, with detailed disclosure of the relationship: Royalties for print or electronic media. Compensation as an author or editor (as allowed within the limits of ABIM s Academic Conflict of Interest Policy). The following intellectual property relationships with industry are compatible with ABIM service, but may require management beyond disclosure, as described in Appendix A: Income from healthcare-related licensing fees. Income from healthcare-related patents. 4
5 Employment by or Service on Boards of Healthcare-related Companies An employment relationship can have considerable influence on the viewpoint of any individual. Therefore, employment by a healthcare-related company may, in some situations, be deemed incompatible with ABIM service. In other situations, employees of healthcare-related companies may bring valuable experience and perspective to ABIM, without unacceptably high risk of industry influence on ABIM decisions. Individuals employed by healthcare-related companies may be considered and selected for board service; management beyond disclosure for these individuals may be required (described in Appendix A). Service on the governing board of a for-profit or not-for-profit healthcare-related company brings with it fiduciary responsibility for the well-being of that company. ABIM recognizes that individuals invited to serve ABIM may also be asked to serve on the governing boards of healthcare-related companies. Such a role is compatible with ABIM service, but must be disclosed, and may require additional management, as described in Appendix A. Unrestricted Grants and Gifts to Individuals Most grant funding from industry, whether for research, education or another activity, clearly specifies the purpose of the funding and the expectations from the recipient of the grant. Unrestricted grants (a transfer of funds from industry to an individual to be used for purposes determined entirely by the individual) have become rare. Unrestricted grants are incompatible with ABIM service because of the risk that this type of grant can bring with it a strong influence from industry on the grant recipient. Gifts to an individual from industry carry a similar risk of strong industry influence and therefore, gifts of any size are incompatible with ABIM service. ABIM service may be permitted with management beyond disclosure (described in Appendix A) in the unusual circumstance when a gift is made to an individual for the development of a program that benefits patients directly. Investments Investments in pharmaceutical and other healthcare-related companies are common. While the chance that the actions of ABIM would have any influence on the stock price of a company is remote, members should make each other aware of investments in companies that make drugs, medical devices or health care technology, with the exception of mutual funds which may contain investments in the health care sector. Investments in companies unrelated to health care do not need to be disclosed. Investments in healthcare-related industry are compatible with ABIM service, but may require management beyond disclosure, as described in Appendix A: Owning stock in publicly held companies that make drugs, medical devices or health care technology (other than as part of a mutual fund). Holding stock options in companies that make drugs, devices or health care technology. Owning stock or equity in privately held companies that make drugs, devices or health care technology. 5
6 Promotional Speaking/Marketing Pharmaceutical companies, device makers and other healthcare-related companies make significant contributions to the health of the public, but they also have a responsibility to stockholders to provide a return on investments through the generation of profits. Because of ABIM s paramount need for independence and because the profession and the public must have no doubts about its independence ABIM members must not engage in activities that are viewed as primarily for the purpose of marketing. The following activities are incompatible with ABIM service, because their primary purpose is linked with the marketing of commercial products: Speaking on behalf of a pharmaceutical company, device maker or other healthcarerelated company, using slides provided by the company (e.g., speakers bureau service). Consulting on marketing plans (e.g., consulting on a post-development advertising campaign strategy). Compensation from a for-profit company for providing assistance to their marketing department and personnel. Not-for-Profit, Healthcare-related Organizations To assure a shared understanding of potential influence on members views, members must disclose grant funding, consulting fees, honoraria and other compensation received from not-for profit healthcare-related organizations, including medical societies and patient advocacy groups. Oversight and Administration If uncertain about these guidelines, individuals are urged to seek the advice of the ABIM Conflict of Interest staff, the Conflict of Interest Subcommittee or the Chair of the Board. Questions about activities not clearly covered by these guidelines will be taken to the Conflict of Interest Subcommittee Chair, who may choose to convene the full Conflict of Interest Subcommittee; members may also request a full Conflict of Interest Subcommittee review. Decisions of the Conflict of Interest Subcommittee concerning permitted and prohibited activities are to be considered final, and the Conflict of Interest Subcommittee may recommend to the Governance Committee sanctions for members found to be in violation of the Financial Conflict of Interest Policy or a decision of the Conflict of Interest Subcommittee, up to and including removal from board service or revocation of certification. Financial COI Policy revised by the Board of Directors on February 8,
7 APPENDIX A: PROCEDURES TO SUPPORT THE ADMINISTRATION OF ABIM CONFLICT OF INTEREST POLICIES The procedures described below are intended to support understanding of and adherence to ABIM's Conflict of Interest Policies, in order to assure the independence of ABIM programs, policies and products. As with the Conflict of Interest Policies, these procedures apply to physician, interprofessional and public members of the Board of Directors, the ABIM Council, the Specialty Boards, the Exam Committees, Medical Knowledge Self-Assessment Product Committees and other standing and ad hoc committees of ABIM that develop ABIM policies or products, referred to collectively as members. A staff conflict of interest committee, including but not limited to the Chief Ethics Officer, a staff physician and staff representing knowledge assessment and medical specialties departments, will support the procedures necessary to administer ABIM s Conflict of Interest Policies. Disclosure Individuals who are being considered for service must complete ABIM's disclosure forms. Their disclosures will be reviewed by ABIM conflict of interest staff, overseen by the Chief Ethics Officer, to assure that new members will be in compliance with ABIM Conflict of Interest Policies. Members will update their disclosures prior to each meeting, and any changes will be reviewed by staff. ABIM asks for detailed information concerning the relationships members have with healthcarerelated industry and organizations in order to judge whether any further management is indicated, and to enable informed and open conversations among boards and committees concerning these relationships. Disclosures will be shared among members who serve together. The disclosures of members of the Board of Directors and the Council are posted on ABIM's public website, and ABIM plans to post the disclosures of all ABIM boards and committees. When members earn more than $25,000 in above-salary income in consulting fees, honoraria or similar income from any single company that produces drugs, devices or health care technology, they will be contacted by a member of the staff conflict of interest committee to learn more about their relationship with the company, in order to determine if additional management beyond disclosure is required. Management Beyond Disclosure If ABIM conflict of interest staff identifies a situation where management beyond disclosure is required, this will be communicated to the member, to the chair of the board or committee on which the member serves, and to relevant staff (e.g., exam developers for Exam Committees and Medical Knowledge Self-Assessment Product Committees, sponsors of Specialty Boards). Because the work varies significantly among the Board of Directors, the Council, the Specialty Boards and the Exam Committees, and Medical Knowledge Self-Assessment Product Committees, different types of management may be indicated for specific groups. Exam Committees, Medical Knowledge Self-Assessment Product Committees and Other Product Development Groups The iterative nature of question development, exam blueprints and the reliance on medical evidence for all questions provides strong protection against bias. The steps described below 7
8 provide further assurance, especially to the public, that there is no industry influence in its products. 1. When members have relationships with industry that are described in the policy as potentially needing management beyond disclosure, any questions they write with content that relates to the area of the relationship will be flagged so that all members can review the questions for unintended bias. The member has an enhanced duty to report the evidence supporting correct answers. The chair will ask specifically if any members have concern about industry influence. 2. When multiple members of a committee have relationships with companies that make products relevant to questions, the committee will consider whether questions favor those products by flagging relevant questions for close review. 3. In some cases, based on recommendations from conflict of interest staff, question writing assignments may be adjusted to reduce risk of industry influence or the perception of industry influence. 4. All groups will have some members with no relationships, and these members can play an important role in adjudicating questions of industry influence. 5. Chairs will ask their committees if anyone has concerns about bias at the end of each day s work. Specialty Boards, Council and Board of Directors The work of the Specialty Boards, the ABIM Council and the Board of Directors may include determining whether or not a product developed by a specialty society or other organization receives credit in ABIM's programs. Therefore, members of these groups who hold leadership positions in societies or other organizations with products under such consideration will need to recuse themselves from voting on those products. For Specialty Boards, if a majority of members have links with a society or organization referral to the Council for a final decision is indicated. Members Free of Financial Relationships with Industry The presence of members free of financial relationships with industry (as defined below) on all boards and committees is important in assuring that the decisions made on behalf of ABIM are free of industry influence. Therefore, by January 1, 2016, Medical Knowledge Self-Assessment Product Committees shall have a minimum of one member free of financial relationships. By July of 2015, all other boards and committees shall have a minimum of two members free of financial relationships with industry. The Conflict of Interest Subcommittee shall review the composition of boards and committees at least annually to determine organizational goals for the minimum number of members free of financial relationships with industry. Definition: Free of Financial Relationships For purposes of establishing whether a member is free of financial relationships, a member whose only financial relationship(s) is one or more of the following may be considered free of financial relationships : Paid editorial work or compensation as an author (as described in the second paragraph of Intellectual Property section above). Service as a site investigator for an industry-funded clinical trial if the following criteria are met: 8
9 o Funding is for trial expenses and clinical research staff only, without salary support for the member. o Funding is provided directly to the institution or practice, not to the member. Financial relationships of his or her spouse/partner, pending review by the Conflict of Interest Subcommittee. Income from stock in publicly traded companies, if none of the product(s) of the company is relevant to the member's decision-making purview. The member's status as being free of financial relationships is a judgment of the Conflict of Interest Subcommittee. Role of the Governance Committee/Conflict of Interest Subcommittee In addition to developing policy that will be voted on by the Board of Directors, the Conflict of Interest Subcommittee provides oversight to staff through review of staff assessment of the Specialty Boards, Exam Committees and Medical Knowledge Self-Assessment Product Committees. The Conflict of Interest Subcommittee also answers questions about member activities that are not addressed in existing policy. Exceptions and Appeals ABIM recognizes that special situations not covered by this policy may occur. The Conflict of Interest Subcommittee will decide on members' requests for exceptions from the Conflict of Interest Policies, and it will decide on appeals from members concerning staff recommendations. The Conflict of Interest Subcommittee will also decide on extensions in situations where boards or committees may need additional time to come into compliance with this policy. The compliance decisions of the Conflict of Interest Subcommittee are the final decisions of the Board of Directors and of ABIM. 9 Appendix A revised by the Governance Committee on June 13, 2016
Office of Research Administration
Revision: 8/10/2016 Effective Date: 8/24/2012 Office of Research Research Policy and Operational Guidance: Financial Conflicts of Interest (FCOI) in PHS-Funded Research and Research Training Oakland University
More informationEuropean Board for Accreditation in Hematology Standards & Guidelines
European Board for Accreditation in Hematology Standards & Guidelines Standards 1 Only CME activities that exclusively benefit hematologists and their patients are eligible for accreditation. 2 Only academic
More informationDISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST Approved: Board of Directors 06/18/88 Revised: Board of Directors 02/27/98 Revised: Board of Directors 03/19/99 Revised: Board of Directors 05/20/06 Revised:
More informationCODE OF ETHICS AND PROFESSIONAL STANDARDS FOR MEMBERS
CODE OF ETHICS AND PROFESSIONAL STANDARDS FOR MEMBERS Contents CODE OF ETHICS... 2 1 CONDUCT OF MEMBERS ACTING ON BEHALF OF THE SOCIETY... 2 2 ORGANIZATIONAL POLICIES... 3 3 SPOKESPERSON CONDUCT... 5 4
More informationCONFLICTS OF INTEREST IN RESEARCH
IM&COI POLICY III CONFLICTS OF INTEREST IN RESEARCH (Capitalized terms are defined in the Glossary.) Presumption Against Participating in Research When Personal Financial Interests Exist If an Investigator
More informationNASPGHAN Mission Statement.
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Policy on Conflict of Interest and Relationships with Industry and Other Organizations. NASPGHAN Mission Statement.
More informationTo: Vice Chancellors, Deans, Administrative Staff, Department Heads, and Students.
Chancellor s Memorandum CM-35 Conflicts of Interest in Research: Managing Potential Financial and Non-Financial Conflicts of Interest of Individuals and the Institution To: Vice Chancellors, Deans, Administrative
More informationIsland Health Guidelines for Commercial Support of Continuing Medical Education/Continuing Professional Development Activities
Continuing Professional Development for Physicians Island Health Guidelines for Commercial Support of The following document outlines the guiding principles pertaining to the support of VIHA sponsored
More informationAmerican Thoracic Society International Conference SUMMARY AND DEFINITIONS OF ATS POLICIES ON CONFLICT OF INTEREST AND TOBACCO INDUSTRY RELATIONSHIPS
Please note: this document is intended as an optional resource for Conference organizers, chairs and presenters, as a summary of information made available on the ATS COI Website and ATS Website. If you
More informationJohns Hopkins University. Policy on Individual Financial Interests and Financial Conflict of Interests 1, 2 in Research
Johns Hopkins University Policy on Individual Financial Interests and Financial Conflict of Interests 1, 2 in Research This policy applies to the Bloomberg School of Public Health, Krieger School of Arts
More informationConflict of Interest Policy. Approved May 2016 Mayo Clinic Board of Governors
Conflict of Interest Policy Approved May 2016 Mayo Clinic Board of Governors Table of Contents I. Overview... 4 A. Guiding Principles... 4 B. What is a Conflict of Interest?... 4 C. What Can Cause a Financial
More informationPolicy on Conflicts of Interest in Clinical Care
Policy on Conflicts of Interest in Clinical Care Approved by FPP Board of Directors: March 16, 2006 Revised and Approved: December 15, 2009, January 18, 2011, January 22, 2013, January 21, 2014, April
More informationCreation Date: 7/1/01 Title: Conflict of Interest Revision History:
RENOWN HEALTH Policies & Procedures Page 1 of 6 Current Version Effective Date: 8/16/17 Creation Date: 7/1/01 Title: Conflict of Interest Revision History: Type: Number: Author(s): Owner: Compliance RENOWN.CCD.500
More informationPaul Lorenz, MBA Chief Executive Officer, SCVMC. Continuing Medical Education (CME) Standards for Commercial Support
Administrative Policies and Procedures Manual VMC # 154.02 October 5, 2013 TO: FROM: SUBJECT: REFERENCES: SCVMC Employees Paul Lorenz, MBA Chief Executive Officer, SCVMC Continuing Medical Education (CME)
More informationGraduate Medical Education Medical Industry Interaction Policy and Procedure. December 18, 2008
Graduate Medical Education Medical Industry Interaction Policy and Procedure December 18, 2008 Purpose: To ensure that all residents and fellows interactions with representatives of the pharmaceutical
More informationAASM Conflict of Interest (COI) Policy September 2016
AASM Conflict of Interest (COI) Policy September 2016 Conflict of Interest (COI) Committee Mandate The committee shall consist of no fewer than 3 and no more than 5 members. Each member of the committee
More informationCollege of Medicine Policy on Pharmaceutical, Medical Device, and Biotechnology. (1) Definitions. The following definitions apply to this regulation:
College of Medicine Policy on Pharmaceutical, Medical Device, and Biotechnology Industry Conflict of Interest (1) Definitions. The following definitions apply to this regulation: (a) COM means the University
More informationConflict of Interest Policy. Approved August 2012 Mayo Clinic Board of Governors
Conflict of Interest Policy Approved August 2012 Mayo Clinic Board of Governors Table of Contents I. Overview... 4 A. Guiding Principles... 4 B. What is a Conflict of Interest?... 4 C. What Can Cause a
More informationAppendix VIII: Conduct of Human Subjects Research in which the University has a significant financial interest Appendix IX: Retrospective
Penn State University College of Medicine (COM) The Penn State Hershey Medical Center (PSHMC) Standard Operating Procedures (SOPs) Regarding Review and Management of Conflict of Interest Version date:
More informationUNIVERSITY OF FLORIDA GUIDELINES, POLICIES, AND PROCEDURES ON CONFLICT OF INTEREST AND OUTSIDE ACTIVITIES, INCLUDING FINANCIAL INTERESTS
UNIVERSITY OF FLORIDA GUIDELINES, POLICIES, AND PROCEDURES ON CONFLICT OF INTEREST AND OUTSIDE ACTIVITIES, INCLUDING FINANCIAL INTERESTS I. Introduction II. Basic Principles of Conflict of Interest with
More informationUPMC POLICY AND PROCEDURE MANUAL
UPMC POLICY AND PROCEDURE MANUAL POLICY: HS-EC1702 * INDEX TITLE: Ethics & Compliance SUBJECT: Policy on Conflicts of Interest and Interactions between Representatives of Certain Industries and Faculty,
More informationConflict of Interest Principles for ASGE Publications and Educational Product Development excluding Gastrointestinal Endoscopy and CME activity
ASGE-COIpolicy_2009 1 Conflict of Interest Principles for ASGE Publications and Educational Product Development excluding Gastrointestinal Endoscopy and CME activity ASGE-COIpolicy_2009 2 Index: Preamble
More informationCommittee Approval(s) Standards Committee 06/19/13. Current Content Expert: Megan Bailey, Manager, Office of Research Compliance
Policy Procedure Originator: Office of Research Compliance Current Content Expert: Megan Bailey, Manager, Office of Research Compliance Department Head: Brent Dethlefs, Director of Research Institute Executive
More informationMAIMONIDES MEDICAL CENTER SUBJECT: CONFLICTS OF INTEREST IN HUMAN RESEARCH & PHS FUNDED RESEARCH
MAIMONIDES MEDICAL CENTER CODE: RES-021 (Reissued) ORIGINALLY ISSUED: October 22, 2009 SUBJECT: CONFLICTS OF INTEREST IN HUMAN RESEARCH & PHS FUNDED RESEARCH I. POLICY Consistent with current law and to
More informationCommercial Support Policy and Procedures. Policy
Commercial Support Policy and Procedures To ensure independence in development and implementation of CME activities from the control by commercial interests, the Case Western Reserve University CME Program
More informationJournal of Clinical Oncology Author Submission preparation worksheet. Author Disclosure Declaration
Journal of Clinical Oncology Author Submission preparation worksheet Each author should complete and return this form to the corresponding author. FOR REFERENCE ONLY DO NOT SEND TO JCO Author Disclosure
More informationUNIVERSITY OF WISCONSIN-STEVENS POINT OFFICE OF RESEARCH AND SPONSORED PROGRAMS
UNIVERSITY OF WISCONSIN-STEVENS POINT OFFICE OF RESEARCH AND SPONSORED PROGRAMS FINANCIAL CONFLICTS OF INTEREST POLICY FOR PUBLIC HEALTH SERVICE (PHS)-FUNDED PROJECTS The University of Wisconsin-Stevens
More informationPHA Policy on Conflict of Interest
PHA Policy on Conflict of Interest A Conflict of Interest (COI) is any affiliation or characteristic of an individual which could (a) interfere with or be perceived to interfere with (i.e. bias) the appropriate
More informationCentral Office of Research Administration
SECTION: PURPOSE STATEMENT To set forth the process for reviewing financial interests, and for identifying and addressing financial conflicts of interest ( FCOI ) in Research (as defined later in this
More informationClemson University Financial Conflict of Interest Policy for PHS/NIH Supported Research
Clemson University Financial Conflict of Interest Policy for PHS/NIH Supported Research Persons covered by this policy This policy applies to all faculty and staff, including all full-time, part-time,
More informationESMO Declaration of Interests (DOI) Statement
ESMO Declaration of Interests (DOI) Statement Purpose and disclaimer As leaders in the field of oncology we all have a responsibility to ensure that our work is presented in the most appropriate fashion
More informationCOURSE DIRECTOR MANUAL
University of Central Florida College of Medicine COURSE DIRECTOR MANUAL 2017-2018 1 TABLE OF CONTENTS Mission Continuous Professional Development Page 3 Forms Faculty Information Form Pages 4-6 Exhibit
More informationAMERICAN CANCER SOCIETY, INC. FINANCIAL CONFLICT OF INTEREST POLICY FOR PROMOTING OBJECTIVITY IN RESEARCH
AMERICAN CANCER SOCIETY, INC. FINANCIAL CONFLICT OF INTEREST POLICY FOR PROMOTING OBJECTIVITY IN RESEARCH Introduction The American Cancer Society, Inc. ( ACS ) seeks excellence in the discovery and dissemination
More informationTable of Contents. IV. Support for Educational and Other Professional Activities:...18
Policy: Conflict of Interest and Commitment Category Compliance Effective Date September 2017 Approval Date September 2017 Supersedes April 2010 Applicable to VUMC Areas (and associated workforce members):
More informationColumbia University MORNINGSIDE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENT
Columbia University MORNINGSIDE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENT This information applies to current activities and any activities anticipated during the next 12 months. NOTE: All underlined
More informationresearch must complete, even if they have used the coi.asco.org system)
JCO Precision Oncology Author Submission Preparation Worksheet FOR REFERENCE ONLY DO NOT SEND TO JCO PO This worksheet contains: 1. Author Disclosure Form (Authors who do not use the coi.asco.org system
More informationFrequently Asked Questions
Medical Imaging and Technology Alliance (MITA) Fact Sheet on Federal and State Medical Device Marketing or Sunshine Disclosure Laws Updated November 16, 2011 A new federal law called the Federal Physician
More informationConflict Of Interest Issues: What You Don t Know Could Hurt You
Conflict Of Interest Issues: What You Don t Know Could Hurt You University of California 2013 Compliance and Audit Symposium Conflict of Interest (COI) Laws and Policies Today s presentation is a brief
More informationcomplying with the State Conflict of Interests Act are described below.
Policy: Financial Conflicts of Interest for Research Investigators Final Date: 8/3/12 Policy ID: RES-005 Status: Migrated Policy Type: University Contact Office: Vice President for Research (Office of)
More informationCONFLICT OF INTEREST: ACCP PUBLICATIONS POLICY AND PROCEDURE
CONFLICT OF INTEREST: ACCP PUBLICATIONS POLICY AND PROCEDURE Background In August 1999, the ACCP Board of Regents approved the policy, Conflict of Interest: ACCP Publications Policy and Procedure. At its
More informationCLARION UNIVERSITY OF PENNSYLVANIA Clarion, Pennsylvania Conflict of Interest Policy Research and Sponsored Projects
CLARION UNIVERSITY OF PENNSYLVANIA Clarion, Pennsylvania 16214 Conflict of Interest Policy Research and Sponsored Projects Objective/Purpose This Conflict of Interest Policy for Research and Sponsored
More informationAll UCSD Health Faculty (Schools of Medicine and Pharmacy) in the Health Sciences Compensation Plan
TO: All UCSD Health Faculty (Schools of Medicine and Pharmacy) in the Health Sciences Compensation Plan FROM: Andrew Ries, M.D., MPH Associate Vice Chancellor, Academic Affairs UC San Diego Health Sciences
More informationThe Japan Society for Transplantation Guidelines on Conflicts of Interest. Introduction
The Japan Society for Transplantation Guidelines on Conflicts of Interest Introduction The Japan Society for Transplantation aims to improve, develop academic research and popularize academic knowledge
More informationNYU LANGONE POLICY ON CONFLICTS OF INTEREST IN BUSINESS AFFAIRS. Issue Date: April 1, 2009 Reissue Date: June 29, Contents: I.
NYU LANGONE POLICY ON CONFLICTS OF INTEREST IN BUSINESS AFFAIRS Issue Date: April 1, 2009 Reissue Date: June 29, 2016 Contents: I. Applicability II. General Policy III. Procedures for Disclosure IV. Review
More informationFinancial Conflict of Interest Policy
NUMBER: 3.3 SECTION: Human Resources REVISION: V2 SUBJECT: Financial Conflict of Interest EFFECTIVE DATE: August 24, 2012 Financial Conflict of Interest Policy PURPOSE InterveXion Therapeutics ( InterveXion
More informationHONORARIA POLICY AND PROCEDURE
HONORARIA POLICY AND PROCEDURE POLICY DESCRIPTION: continuing medical education Policy Governing Honoraria and Reimbursement of Expenses for physicians, and scientists in the role of invited speakers.
More informationFinancial Conflict of Interest. V001 November 14, 2014
Financial Conflict of Interest November 14, 2014 Table of Contents 1 Policy Description... 3 2 Introduction and Scope... 3 3 Definitions... 3 3.1 Terms... 3 3.2 Acronyms... 4 4 Procedure... 5 4.1 Part
More informationUNI Office of Research and Sponsored Programs Policy on Conflicts of Interest Involving Research Funded by the Public Health Service
UNI Office of Research and Sponsored Programs Policy on Conflicts of Interest Involving Research Funded by the Public Health Service 8-22-12 Purpose of Policy The purpose of this policy is to ensure that
More informationConflict of Interest (COI): What s All the Buzz About?
Conflict of Interest (COI): What s All the Buzz About? ACCR Lecture: 9/21/12 Julia M. Campbell Director, COI Topics for Discussion Impetus and environment prompting new COI regulations Case studies Overview
More informationThe Physician Payments Sunshine Law and you: Building stronger industry - physician interactions
The Physician Payments Sunshine Law and you: Building stronger industry - physician interactions 1 What is the timing of the Sunshine Law requirements? Aug. 1, 2013: Manufacturers are required to begin
More informationInvestigator Financial Conflict of Interest Policy
615 Westlake Avenue N Seattle, Washington 98109 206.548.7000 phone Effective June 7, 2018 Updated July 31, 2018* Investigator Financial Conflict of Interest Policy Background: The Allen Institute is committed
More informationGUIDANCE: Financial Conflicts of Interest NUMBER DATE AUTHOR APPROVED BY AUDIENCE USE PAGE
Page 1 of 5 1 PURPOSE 1.1 This guidance establishes the methodology by which (a) the Sharp HealthCare (SHC) Review Board (IRB) will require the reporting of personal and institutional financial interests
More informationWhite Paper: Formulary Development at Express Scripts
White Paper: Formulary Development at Express Scripts Express Scripts works with health-benefit plan sponsors and individual members of health plans to provide affordable access to clinically sound, high-quality
More informationCONFLICTS OF INTEREST IN RESEARCH - INDIVIDUAL
PAGE: 1 of 15 1. PURPOSE To outline requirements for the disclosure, review, management, reporting and monitoring of Significant Interests related to Research that are held by Investigators and those involved
More informationManaging conflicts of interest in the EAU Guidelines GO Policy
Managing conflicts of interest in the EAU Guidelines GO Policy To avoid criticism say nothing, do nothing, be nothing (Aristoteles) Authors: Guidelines Office COI Committee (members): Prof.Dr. A. Bjartell
More informationCAROLINAS HEALTHCARE SYSTEM OFFICE OF CLINICAL AND TRANSLATIONAL RESEARCH STANDARD OPERATING PROCEDURE
CAROLINAS HEALTHCARE SYSTEM OFFICE OF CLINICAL AND TRANSLATIONAL RESEARCH STANDARD OPERATING PROCEDURE Procedure No.: A-106 Title: Disclosure and Management of Significant Financial Interest in CHS Research
More information3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION
1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB endeavors to conform to pertinent
More informationPHYSICIAN PAYMENTS SUNSHINE ACT (OPEN PAYMENTS) Mary Evelyn Armstrong MA, CRA Conflict of Interest Officer
PHYSICIAN PAYMENTS SUNSHINE ACT (OPEN PAYMENTS) Mary Evelyn Armstrong MA, CRA Conflict of Interest Officer WHAT IS IT? Section 6002 of the Affordable Care Act requires the establishment of a transparency
More informationMASSACHUSETTS INSTITUTE OF TECHNOLOGY POLICY AND PROCEDURES ON CONFLICTS OF INTEREST IN RESEARCH
MASSACHUSETTS INSTITUTE OF TECHNOLOGY POLICY AND PROCEDURES ON CONFLICTS OF INTEREST IN RESEARCH POLICY STATEMENT A conflict of interest (COI) can be any situation in which financial or other personal
More informationFinancial Conflict of Interest Policy and Procedural Manual
Financial Conflict of Interest Policy and Procedural Manual Financial Conflict of Interest... 1 Policy and Procedural Manual... 1 Financial Conflict of Interest Policy... 2 Disclosure of Financial Conflicts
More informationSpeaker Acknowledgement of Copyright Guidelines
ALD SPEAKER PACKET Thank you for sharing your knowledge and experience with the audience of this ALD event. As a presenter, you are required to acknowledge the information shared in the following pages
More informationDisclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi
Disclosure 2015 Methodological Note For Aventis Pharma Ltd trading as Sanofi INTRODUCTION The EFPIA Disclosure Code requires all EFPIA member companies to disclose transfers of value (TOV) such as support
More informationCancer Science Conflict of Interest Policy
Updated on 15 February 2018 Cancer Science Conflict of Interest Policy The Japanese Cancer Association (JCA) requires authors, editors and reviewers, to disclose any potential conflict of interest related
More informationHCP CODE: GLOBAL CODE ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS
HCP CODE: GLOBAL CODE ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS HCP CODE: GLOBAL CODE ON INTERACTIONS WITH HEALTHCARE PROFESSIONALS PREAMBLE: We, at Galderma, are committed to delivering innovative
More informationCONFLICT OF INTEREST POLICY
Policy Section Name Policy Category Policy Number Supersedes: Corporate Corporate 300CO-CO-005 n/a Organizational Scope IPC (Yes/No) Effective Date Next Review Date ICES-Network (sitespecific procedures)
More informationMONTEFIORE HEALTH SYSTEM ADMINISTRATIVE POLICY AND PROCEDURE
MONTEFIORE HEALTH SYSTEM ADMINISTRATIVE POLICY AND PROCEDURE SUBJECT: CONFLICT OF INTEREST NUMBER: JH20.1 OWNER: DEPARTMENT OF COMPLIANCE EFFECTIVE: REVIEW/REVISED: SUPERSEDES: 10/15 10/15 CROSS-REFERENCE:
More informationTITLE: Conflict of Interest, Research
PAGE 1 of 8 TITLE: Conflict of Interest, Research IDENTIFIER: S-FW-LD-0004 APPROVED: Executive Cabinet 12/11/12 ORIGINAL FORMULATION: 12/08 REVISED: 12/12 REVIEWED: 06/12 EFFECTIVE: Acute Care: ENC: 12/17/12
More informationConflicts of Interest - Research and Sponsored Programs
Conflicts of Interest - Research and Sponsored Programs This Policy is Applicable to the following sites: Continuing Care, Corporate, Gerber, Outpatient/Physician Practices, Priority Health, Reed City,
More informationUniversity of New England Investigator Significant Financial Interest Disclosure Policy for Sponsored Projects Originally Adopted March 2005
University of New England Investigator Significant Financial Interest Disclosure Policy for Sponsored Projects Originally Adopted March 2005 Revised August 2012 Table of Contents Introduction... 3 Background...
More informationJohnson & Johnson Financial Conflicts of Interest Policy
Johnson & Johnson Financial Conflicts of Interest Policy I. INTRODUCTION A. Purpose This policy implements U.S. federal requirements pertaining to Objectivity in Research promulgated by the Public Health
More informationMODEL POLICY [INSERT NAME OF YOUR ORGANIZATION] CONFLICT OF INTEREST POLICY APPLICABLE TO A SUBAWARD ISSUED UNDER A PUBLIC HEALTH SERVICES PRIME AWARD
MODEL POLICY [INSERT NAME OF YOUR ORGANIZATION] CONFLICT OF INTEREST POLICY APPLICABLE TO A SUBAWARD ISSUED UNDER A PUBLIC HEALTH SERVICES PRIME AWARD The federal Public Health Service (PHS) has adopted
More informationII. POLICY STATEMENT RELATING TO CONFLICTS OF INTEREST
THE UNIVERSITY OF ALABAMA POLICY ON CONFLICT OF INTEREST/FINANCIAL DISCLOSURE IN RESEARCH AND OTHER SPONSORED PROGRAMS I. BACKGROUND The University of Alabama (UA) realizes that actual or potential conflicts
More informationPROCEDURES FOR EVALUATING CONFLICTS OF INTEREST AND COMMITMENT
UNIVERSITY OF COLORADO DENVER PROCEDURES FOR EVALUATING CONFLICTS OF INTEREST AND COMMITMENT [Effective August, 17 2015] Approved by the Conflict of Interest and Commitment Committee on 8-17-15 Approved
More informationPOLICY NO.: BHSF POLICY TITLE: Individual Financial Conflicts of Interest (FCOI) in Research
A dm inis trative Departmental POLICY TITLE: Individual Financial Conflicts of Interest (FCOI) in Research SUMMARY & PURPOSE: The purpose of this policy and procedure is to promote objectivity in research
More informationMEDICAL PRACTICE PLAN RULES AND REGULATIONS
MEDICAL PRACTICE PLAN RULES AND REGULATIONS FOR THE LEBANESE AMERICAN UNIVERSITY GILBERT AND ROSE-MARIE CHAGOURY SCHOOL OF MEDICINE PHYSICIANS PRACTICING AT THE LEBANESE AMERICAN UNIVERSITY MEDICAL CENTER-RIZK
More informationAdministrative Procedure, AP Procedures for Disclosing and Addressing Conflicts of Interest and Commitment. Page 1 of 14
Administrative Procedure, AP 12.304 Procedures for Disclosing and Addressing Conflicts of Interest and Commitment Page 1 of 14 Administrative Procedure Chapter 12, Research Administrative Procedure Section
More informationResearch Financial Conflict of Interest Policy. I. Policy Statement
Research Financial Conflict of Interest Policy I. Policy Statement The Donald Danforth Plant Science Center (the Center ) recognizes its responsibility to ensure that research activities are conducted
More informationObjectivity in Research and Investigator Financial Disclosure
Objectivity in Research and Investigator Financial Disclosure Scope This policy applies to Mount Mary University employees who serve as investigators and who apply for funding through Mount Mary University
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca Pharma Poland Sp. z o.o. 0000117902 Postepu 14, 02-676 Warsaw Contents 1. Introduction...
More information1. Disclosure of Significant Financial Interest means an Investigator s disclosure of significant financial interests to Monmouth University.
FINANCIAL CONFLICT OF INTEREST AND OBJECTIVITY IN RESEARCH I. PURPOSE Monmouth University believes that it is vital to maintain objectivity in research and that all research must be conducted with the
More informationNOTES ON CONFLICT OF INTEREST
NOTES ON CONFLICT OF INTEREST These notes on Conflict of Interest are based on the current University of North Carolina at Charlotte policy, the implementation of a new electronic disclosure system (AIR),
More informationLSUHSC-NO Chancellor s Memorandum (CM-35)
LSUHSC-NO Chancellor s Memorandum (CM-35) Individual and Institutional Conflicts of Interest in Sponsored Projects Updated 4/26/2017 CM-35 An Investigator shall not be permitted to begin any research activity
More informationState of New Jersey. Department of Education. Code of Ethics
State of New Jersey Department of Education Code of Ethics Revised: March 11, 2003 Adopted: July 3, 2003 Department of Education Code of Ethics Table of Contents Pages I. Purpose 1 II. Applicability 1
More informationTitle: Previous Version(s): 8/01, 1/02, 6/06, 1/12, 4/12
Title: Financial Conflicts of Interest Department: Research Institute Effective Date: 3/18 Reviewed: Previous Version(s): 8/01, 1/02, 6/06, 1/12, 4/12 Policy & Procedure Replaces: Disclosure of Conflicts
More informationAN ACT TO ESTABLISH RATE SETTING OF PRESCRIPTION DRUGS IN [STATE]
1 1 1 1 1 1 1 0 1 0 1 AN ACT TO ESTABLISH RATE SETTING OF PRESCRIPTION DRUGS IN [STATE] Whereas prescription medications are as important to the health and safety of State residents as traditional public
More informationARPIM HCP/HCO DISCLOSURE CODE
ARPIM HCP/HCO DISCLOSURE CODE ARPIM CODE ON THE DISCLOSURE OF SPONSORSHIPS AND OTHER TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)
More informationCORPORATE COMPLIANCE: CONFLICT OF INTEREST
CORPORATE COMPLIANCE: CONFLICT OF INTEREST Conflict of Interest (CC1208) KEY WORDS: Disclosure of Financial Relationships, Conflict of Interest, Human Subjects Research OBJECTIVE/BACKGROUND: Board Members,
More informationTakeda Belgium - Methodological note 2015
Takeda Belgium - Methodological note 2015 Accompanying document for the public transparency of transfer of value to Healthcare Professionals and Healthcare Organisations 1. General introduction... 2 2.
More informationXAVIER UNIVERSITY. Financial Conflict of Interest Policy-Non-Federal Grant Proposals
Effective Date: XAVIER UNIVERSITY Financial Conflict of Interest Policy-Non-Federal Grant Proposals Last Updated: May 2013 Responsible University Office: Office of Grant Services Responsible Executive:
More informationFinancial Conflict of Interest (FCOI) Standard Operating Procedures
Financial Conflict of Interest (FCOI) Standard Operating Procedures Financial Conflict of Interest (FCOI) Standard Operating Procedures Table of Contents SOP# Title Page # FCOI 01 Purpose and Applicability
More informationMANUAL OF UNIVERSITY POLICIES PROCEDURES AND GUIDELINES. Applies to: faculty staff students student employees visitors contractors
Page 1 of 6 Applies to: faculty staff students student employees visitors contractors Effective Date of This Revision: December 15, 2016 Contact for More Information: Office of Research and Graduate Studies
More informationStandard Operating Procedures for Disclosure and Management of Financial Conflicts of Interest
Standard Operating Procedures for Disclosure and Management of Financial Conflicts of Interest Effective May 1, 2013 TABLE OF CONTENTS 1.0 GENERAL PRINCIPLES... 3 2.0 SCOPE... 3 3.0 GUIDING PRINCIPLES...
More informationAuburn University Procedures for Public Health Service Financial Conflicts of Interest Regulations
1 Auburn University Procedures for Public Health Service Financial Conflicts of Interest Regulations Introduction The Public Health Service (PHS) has issued its final rule entitled Responsibility of Applicants
More informationInterim Rule 7-006: Institutional Financial Con icts of Interest for Research Involving Human Subjects OUTDATED
Interim Rule 7-006: Institutional Financial Con icts of Interest for Research Involving Human Subjects I. Purpose and Scope The University of Utah recognizes that certain interests held by the University
More informationTEMPLE UNIVERSITY BOARD OF TRUSTEES POLICIES AND PROCEDURES MANUAL
TEMPLE UNIVERSITY BOARD OF TRUSTEES POLICIES AND PROCEDURES MANUAL Title: Financial Conflict of Interests in Research Policy Number: 02.52.12 Issuing Authority: President Responsible Officer: Senior Vice
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 AstraZeneca UK Limited Registered in England No 3674842 Registered Office, 2 Kingdom Street, London,
More informationInvestigator Conflicts of Interest in Funded Research
Corporate Compliance - Procedure No. CCP 4.013 PROCEDURE TITLE: EFFECTIVE DATE: 11/1/2017 Investigator Conflicts of Interest in Funded Research To be reviewed every three years by: Financial Conflict of
More informationReporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018
Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018 Predstavništvo AstraZeneca UK Limited 29004463 15 Bulevar Vojvode Misica, 11 000 Belgrade, Serbia
More informationThe JAMS COI Management Guidance on Eligibility Criteria for Clinical Practice Guideline Formulation March, 2017
The JAMS COI Management Guidance on Eligibility Criteria for Clinical Practice Guideline Formulation March, 07 Table of Contents. Background. Those subject to COI management. Disclosure items and self-disclosure
More informationCODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS TITLE 5 CHAPTER XLV DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 5501 SUPPLEMENTAL STANDARDS OF ETHICAL CONDUCT FOR EMPLOYEES OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
More information